161 related articles for article (PubMed ID: 19108988)
1. Mixed models showed no need for initial response monitoring after starting antihypertensive therapy.
Bell KJ; Hayen A; Macaskill P; Craig JC; Neal BC; Irwig L
J Clin Epidemiol; 2009 Jun; 62(6):650-9. PubMed ID: 19108988
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
Holzgreve H; Risler T; Trenkwalder P
Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588
[TBL] [Abstract][Full Text] [Related]
3. Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension.
Laurent S
J Hypertens Suppl; 2001 Nov; 19(4):S9-14. PubMed ID: 11848262
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients.
Mourad JJ; Le Jeune S
Curr Med Res Opin; 2009 Sep; 25(9):2271-80. PubMed ID: 19627177
[TBL] [Abstract][Full Text] [Related]
5. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.
Dufouil C; Chalmers J; Coskun O; Besançon V; Bousser MG; Guillon P; MacMahon S; Mazoyer B; Neal B; Woodward M; Tzourio-Mazoyer N; Tzourio C;
Circulation; 2005 Sep; 112(11):1644-50. PubMed ID: 16145004
[TBL] [Abstract][Full Text] [Related]
6. The impact of one or two missed doses on the duration of action of combined perindopril and indapamide.
Myers MG; Leenen FH;
J Hum Hypertens; 2007 Jan; 21(1):86-93. PubMed ID: 17066085
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination.
Asmar RG; London GM; O'Rourke ME; Mallion JM; Romero R; Rahn KH; Trimarco B; Fitzgerald D; Hedner T; Duprez D; De Leeuw PW; Sever P; Battegay E; Hitzenberger G; de Luca N; Polónia P; Bénétos A; Chastang C; Ollivier JP; Safar ME;
J Hypertens Suppl; 2001 Nov; 19(4):S15-20. PubMed ID: 11848258
[TBL] [Abstract][Full Text] [Related]
8. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
Dolan E; Stanton AV; Thom S; Caulfield M; Atkins N; McInnes G; Collier D; Dicker P; O'Brien E;
J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME
J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203
[TBL] [Abstract][Full Text] [Related]
10. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial.
Arima H; Chalmers J; Woodward M; Anderson C; Rodgers A; Davis S; Macmahon S; Neal B;
J Hypertens; 2006 Jun; 24(6):1201-8. PubMed ID: 16685221
[TBL] [Abstract][Full Text] [Related]
11. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.
Chalmers J; Neal B; MacMahon S;
J Hypertens Suppl; 2000 May; 18(1):S13-9. PubMed ID: 10939785
[TBL] [Abstract][Full Text] [Related]
12. Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease.
Heerspink HJ; Ninomiya T; Perkovic V; Woodward M; Zoungas S; Cass A; Cooper M; Grobbee DE; Mancia G; Mogensen CE; Neal B; Chalmers J;
Eur Heart J; 2010 Dec; 31(23):2888-96. PubMed ID: 20501479
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the antihypertensive efficacy and tolerability of fixed very low-dose perindopril/indapamid combination in patients with mild to moderate hypertension. Results of a Czech and Slovak multicentric study].
Widimský J; Fedelesová V
Vnitr Lek; 2004 Jun; 50(6):447-52. PubMed ID: 15346638
[TBL] [Abstract][Full Text] [Related]
14. Low-dose fixed combination of perindopril plus indapamide in the diabetic hypertensive population.
Barrios V; Escobar C; Divison JA; Medialdea F
Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1063-9. PubMed ID: 18793109
[TBL] [Abstract][Full Text] [Related]
15. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A;
J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849
[TBL] [Abstract][Full Text] [Related]
17. Renal protection in diabetic patients: benefits of a first-line combination of perindopril-indapamide (Preterax).
Ruilope LM; Segura J
J Hypertens Suppl; 2006 May; 24(3):S9-12. PubMed ID: 16723864
[TBL] [Abstract][Full Text] [Related]
18. [PROGRESS Study examines transient cerebral ischemia and stroke patients. Future goal: attaining basic blood pressure control].
Einecke D
MMW Fortschr Med; 2001 Jul; 143(26-27):4-5. PubMed ID: 11481915
[No Abstract] [Full Text] [Related]
19. [PROGRESS--a trial on blood pressure lowering after stroke and TIA. ACE inhibitors and diuretics reduce the risk of new stroke].
Terént A
Lakartidningen; 2002 May; 99(20):2286-8, 2291. PubMed ID: 12082946
[No Abstract] [Full Text] [Related]
20. Effectiveness and Adherence to Treatment with Perindopril/Indapamide/Amlodipine Single-Pill Combination in a Greek Population with Hypertension.
Tsioufis K; Douma S; Kallistratos MS; Manolis AJ
Clin Drug Investig; 2019 Apr; 39(4):385-393. PubMed ID: 30790132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
